Fred Kemp

Commercial Lead for the Thames Valley & Surrey Secure Data Environment and for the translation of research and innovation into clinical care at Oxford University Hospitals.

TVS SDE is one of the regional SDEs in the NHS Research Secure Data Environment Network, hosted by OUH, giving approved researchers from academia, industry and the NHS secure access to de-identified, linked health and care dat

Commercial lead for TVS SDE, one of the regional SDEs in the NHS Research Secure Data Environment Network, hosted by OUH. I built and lead its commercial and finance function, own the commercial model and pricing, and sit on the SDE senior leadership team. Full description under Head of Commercial, Data and Innovation.

During my time at Oxford University Innovation, I supported the commercialisation of an ever-growing portfolio of digital health and medtech innovations from the University, the Oxford University Hospitals NHS Foundation Trust, and the Oxford Health NHS Foundation Trust, through a broad range of routes: from traditional technology licensing, partnering, and spinouts; through SaaS, open source and

Worked as Board Observer at Oxford Brain Diagnostics Ltd.

Worked as Non Executive Director at MoA Technology.

Worked as Board Observer at Ultromics — Revolutionising Cardiovascular Diagnosis.

Exocyte is developing a real-time multiplexing detection platform for applications in-
(a) Healthcare (ARDS; paediatric sepsis; burns/ wounds/ trauma; acute, chronic & infected wounds)
(b) Defence (CBRNE detection, exposure & patient monitoring)
(c) Energy (enhanced oil recovery, microbial-influenced corrosion, reservoir souring and biofuel supply chain integrity monitoring).

Exocyte also partne

Worked as Board Observer at Zegami .

Worked as Board Observer at Navenio Ltd.

Worked as Board Observer at Oxford Nanoimaging.

I managed an ever-growing portfolio of software projects originating from research groups across the University of Oxford, working closely with academics to identify and protect novel software IP, to increase technology readiness through translational funding, and to secure licensing agreements through targeted marketing and working with selected external companies.

As well as providing hands-on expertise in all types of biotechnology R&D, I have a particular strength in molecular interaction analysis, from high-throughput small molecule screening to in-depth kinetic and thermodynamic analysis, using technologies such as Biacore SPR and Microcal ITC, as well as providing customised training solutions.

Exocyte consultants have a huge range of experience in L

I was brought in to work with Genzyme's Quality Control Group to project manage the integration of GxP Biacore technology into their suite of pharmaceutical release tests.

In addition to authoring all the instrument validation documentation, developing SOPs and training their QC analysts, I was also responsible for the transfer and verification of an existing Biacore release assay from one of Ge

After many years as a Biacore user, I joined GE Healthcare as an Application Specialist within the Life Sciences division, supporting Biacore and Microcal Label Free Interaction Analysis Technologies, and providing specialist support and training to new and existing users in the South West and Ireland.

Whilst I greatly enjoyed the role, further extending my network within the biotech community an

As well as providing hands on expertise in all types of molecular interactions and kinetics (primarily using Biacore technology), I am happy to provide advice, analysis and troubleshooting in a wide range of areas based on my scientific and technological experience.

Exocyte consultants have a huge range of experience in Life Sciences, Pharmaceuticals, Biotechnology and IT - if you think we migh

As CSO, I am responsible for overseeing and driving forward every aspect of the development of our detection technology, whilst maintaining a clear overall vision of how it can best fulfil our clients needs.

I ran a kinetic analysis and molecular interaction service using Biacore Surface Plasmon Resonance technology. This was available to external commercial clients as well as internal and external academic collaborators. With over ten years experience in the field, resulting in a number of peer reviewed publications, my services are well respected within the UK, and I am frequently recommended by Bia

In this role I coordinated not only the development of a new faculty site, but also the updating of all school and departmental sites within the faculty to a visually cohesive web style, with separate templates for each. I also moved the majority of research and teaching content into a content management system that I developed myself using WebObjects and a SQL database. As a direct result of our

After my PhD I continued my work on the physicochemical properties of the CRF-Binding Protein, as well as working on a collaborative BHF-funded research project with a group at UCL, looking into the effect of hypoxia on cardiac myocytes.

It was during this time also that my interest and expertise grew in Biacore SPR technology, to the extent I was offered a centrally-funded Senior Research Fello